Prolonged Survival Using Outpatient Palliative Chemotherapy in Two Children With Refractory Acute Myelogenous Leukemia.
Rebecca E MacDonell-YilmazEmily Vistica SampinoLaura MoynihanWen-I ChangPhilippa G SprinzPublished in: Journal of pediatric hematology/oncology (2023)
We describe 2 pediatric patients with relapsed/refractory AML who achieved disease control and acceptable quality of life utilizing outpatient palliative chemotherapy for over 12 months. These regimens should be considered in patients who no longer desire cytotoxic chemotherapy or are ineligible for further aggressive approaches.
Keyphrases
- acute myeloid leukemia
- locally advanced
- palliative care
- liver failure
- acute lymphoblastic leukemia
- young adults
- advanced cancer
- squamous cell carcinoma
- radiation therapy
- allogeneic hematopoietic stem cell transplantation
- respiratory failure
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- free survival